Adasuve Articles

Alexza deal with Teva sets stage for Adasuve, say analysts

23 May 2013

Teva pays $40 million upfront to market Alexza's Adasuve in USA

9 May 2013

Positive EU regulatory news for Alexza and Ferrer, but not Gentium

22 February 2013

Positive recommendations from EMA's CHMP for Selincro, Adasuve and Perjeta

17 December 2012

FDA sets PDUFA date for Alexza's resubmission for Adasuve

8 July 2012

Alexza rockets on re-submission of Adasuve NDA

25 June 2012

FDA again rejects Alexza's Adasuve, citing manufacturing deficiencies

7 May 2012

PDUFA goal date for Alexza’s Adasuve extended, as Public Citizen says drug should not be approved

25 January 2012

ISTA Pharma rejects Valeant’s advances; Alexza could be for sale

19 December 2011

FDA advisory panel backs Alexza antipsychotic drug

15 December 2011

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end